Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
2022 Serialization Readiness Survey
The seventh edition of the HDA Research Foundation's survey shares the current readiness of manufacturers and distributors to meet Drug Supply Chain Security Act (DSCSA) requirements.
Chip Davis Shares HDA’s 2025 Policy Priorities in Annual Chain Drug Review Column
In his annual “Health Care Outlook” column featured in Chain Drug Review, HDA’s President and CEO Chip Davis outlines a series of key policy priorities for healthcare distributors in 2025, as well as some challenges he expects the industry to face.